large-vessel stroke and it was significantly lower in patients with stroke of unknown etiology than in patients with stroke of other causes (relative risk [RR], 1.7; 95% confidence limits [CL], 1.0 to 2.7; and RR, 0.1; CL, 0 to 0.6; respectively). Recurrent strokes occurred in 23 patients (9%) and were fatal in 9. Another 37 patients were treated by a cardiologist during follow-up; 3 had had a myocardial infarct. Fourteen additional patients needed major vascular surgery. Outcomes with the Glasgow Outcome Scale and Barthel Index were generally favorable. Still, only 49% of patients were still alive, were not disabled, had not suffered from recurrent vascular events, or had not undergone major vascular surgery. Only 42% of survivors had returned to work. A majority of survivors reported emotional, social, or physical residuals that lessened the quality of life.
Conclusions The risks of recurrent vascular events in young adults who have had ischemic stroke are considerable. In addition, a majority of survivors will have residual emotional, social, or physical impairments that hamper employment or lower the quality of life. Further research on the quality of life for young adults who survive stroke is needed. (Stroke.
Key Words • adult cerebral ischemia prognosis young sons. 112 However, information about the long-term prognosis for young adults with ischemic stroke is limited. 4 - 710111314 Bogousslavsky and Regli 7 reported one nonvascular death, two fatal strokes, and one nonfatal stroke among 35 patients, aged 30 years or less, who were observed for up to 3.8 years. During a mean follow-up of 4 years, an Italian study noted a 3% subsequent mortality and a 5% rate of recurrent stroke. 11 Chancellor et al 4 followed 59 patients; they noted two deaths caused by vascular disease and one recurrent stroke during a mean follow-up of 3 years. The quality of life among survivors has also not been extensively studied. To study long-term mortality and morbidity, we have performed a follow-up study in patients that were entered in the Iowa registry of ischemic stroke in young adults. The possible causes of ischemic stroke have been described earlier in a part of the same cohort. 6 -15 This registry also provides the opportunity to obtain information about the occurrence of recurrent vascular events and the functional outcomes among these young adults. Because of the large size of our cohort, we are also able to evaluate the influence of the cause of stroke on subsequent vascular events or deaths.
Subjects and Methods
All patients aged 15 through 45 years with an ischemic stroke who were treated between July 1, 1977, and January 1, 1992, in the Division of Cerebrovascular Diseases of the Department of Neurology of the University of Iowa Hospital and Qinics were included in this study. All patients underwent extensive ancillary examinations to assess the cause of the stroke. 6 Obviously, the diagnostic workup changed over the 15 -year period. The ancillary investigations performed in our cohort of young adults with ischemic stroke were selected on a case-by-case basis; these investigations are described in more detail in a study of 329 patients that includes those seen since the the completion of this project (H.P. Adams, Jr, personal communication, 1993) . Transthoracic echocardiography was abnormal in 82 of 221 examined patients. Transesophageal echocardiography was performed in 28 patients. Arteriography was performed in 227 patients and was abnormal in 146. Ultrasound studies were performed in 70 patients. Extensive coagulation testing was performed in 46 patients, while 189 underwent measurement of cholesterol level and 120 had examination of triglyceride levels. The University of Iowa Hospital and Clinics is a tertiary-level care facility that receives referred patients from physicians in Iowa and adjacent states. Causes of ischemic stroke were categorized as largevessel atherosclerosis, small-vessel disease, cardioembolism, hematologic causes, other causes including nonatherosclerotic vasculopathies, or undetermined. 6 A letter and questionnaire approved by the institutional review board of the University of Iowa was mailed to all patients with a known current address. The patients were asked to fill out a questionnaire and to come to the outpatient clinic for a follow-up clinical assessment. Patients who did not respond within 1 month were contacted by phone and asked to return their questionnaire, or as an alternative, the questionnaire was completed by telephone interview. Information about patients who did not return the questionnaire was obtained from their last known personal physician or by means of their medical record. In such circumstances, the date of the last visit was used as the follow-up date. When a patient could not be contacted by direct mail or via follow-up communication with their personal physician, we contacted the US Internal Revenue Service (IRS). Whereas the IRS does not inform the investigators of the location or status of any person, they were willing to forward our questionnaire in a separate mailing. Patients had the choice of responding or not, but we were not given any information about the patients who did not answer. Finally, the local offices of the Social Security Administration were approached to determine if patients for whom we had no follow-up information had died. Data about the time and cause of death were obtained from medical records, an interview with the treating physician, or from the death certificate. Vascular death was defined as fatal stroke or death from cardiac disease, including sudden death.
The questionnaire included inquiries about cardiac events, recurrent strokes, other vascular diseases, or cardiovascular or cerebrovascular surgery that occurred after the initial stroke. In addition, current risk factors for vascular disease and current medications were recorded. We also asked about rehabilitation after stroke and about their impressions on the usefulness of physical, occupational, speech, and vocational therapy. Information about current disability and quality of life were obtained with the modified Barthel Index (BI) 16 and parts of the SF-36 Health Status questionnaire (SFHQ). 17 During the visits at the outpatient department, neurological impairments were graded by means of the National Institutes of Health stroke scale 18 for measuring general handicap and overall outcome. 20 If a patient could not be examined, we estimated this score using information from the chart or from the questionnaire.
Data were analyzed by means of the EPI INFO statistics program for epidemiology on microcomputer. 21 Categorial data were analyzed with the x 2 test. Survival curves were analyzed with EGRET statistical software. 22 
Results
One patient was excluded because the diagnosis was changed to multiple sclerosis. Data collected from 296 patients were included in this study ( Table 1) ; 158 of the patients were men (53%). In 10 patients (3%), follow-up information was marginal; all of them were still alive, but we were unable to obtain further information. Sex, race, age, vascular risk factors, date of stroke, and stroke subtypes of these 10 patients were not different from those in the other patients. Twenty-one patients (7%) died as a direct result of the initial stroke. Forty patients (14%) died during follow-up. In 12 patients (4%), information could be obtained only by chart review or from the last known family physician; this was used only for assessment of death, recurrent strokes, or other vascular diseases. The questionnaire was filled out by the remaining 213 patients, and 78 of these returned for follow-up examination. The mean time of follow-up was 6 years (median, 5.6; range, 0.02 to 16 years).
Baseline characteristics and the presumed causes of the qualifying stroke are summarized in Table 2 . Total survival is reflected in Fig 1. During follow-up the calculated annual mortality from vascular death was 1.7%. The causes of death are recorded in Table 3 . Patients with small-vessel stroke or stroke of unknown cause significantly more often survived the initial stroke than patients with other stroke subtypes (P<.001 in both). At the end of the follow-up period, mortality was significantly higher among patients who had a stroke secondary to large-vessel stroke and significantly lower in patients with stroke of unknown etiology than among patients with stroke of other causes (relative risk [RR], 1.7; 95% confidence limits [CL], 1.0 to 2.7; and RR, 0.1; CL, 0 to 0.6; respectively). None of the 55 patients aged 25 years or younger at the time of stroke died during follow-up compared with 40 of 220 (18%) patients who were 26 to 45 years of age (P<.001, Fisher's exact test). 
Baseline n=296
(%)
27 (9) 46 (16) 85 (29) 28 (9) 46 (16) 64 (22) 282 (95) 9 (3) 5 (2) 64 (22) 62 (21) 27 (9) 19 (7) 78 (24) 46 (16) 162 (57) 84 (29) 30 (21) 36 (18) 17 (19) information was available, we did not categorize any recurrent strokes by subtype. The incidence of vascular death, stroke, or nonfatal myocardial infarction was constant during the follow-up period and occurred in 43 patients (16%) who survived the initial stroke (2.6% per year; Fig 2) . During follow-up, vascular death or stroke occurred significantly more often among patients whose initial stroke was caused by large-vessel atherosclerosis than among patients with other stroke subtypes (RR, 2.0; CL, 1.1 to 3.6). Even though they did not have recurrent cerebrovascular symptoms, 37 patients reported that they had been treated for heart disease; 16 had a cardioembolic stroke at baseline. Three patients had a nonfatal myocardial infarct during the follow-up period; 1 of them suffered from an earlier recurrent stroke. Twentyseven patients had major vascular surgery during followup; 12 of these patients were also treated for heart disease, and 1 also had a recurrent stroke.
In the questionnaire, treatment with warfarin, aspirin, or dipyridamole was reported by 121, 46, and 6 patients, respectively. Eleven patients were being treated with both aspirin and dipyridamole, and 4 patients took both aspirin and warfarin. Smoking habits changed substantially: approximately 1 out of 4 of the patients who were smokers at the time of their initial stroke had stopped at the time of the follow-up assessment. No woman was using oral contraceptives at the time of the latest evaluation. One third of the patients reported current treatment for hypertension, although half of these patients were not known to be hypertensive at the time of the stroke. Conversely, 10% of the patients who had been diagnosed as having hypertension were no longer receiving therapy for elevated blood pressure at the time of the follow-up examination.
The outcomes that could be assessed among survivors was generally very good: 170 (76%) had minimal or no problems (GOS score of 1), 39 (17%) had moderate handicaps (GOS score of 2), and only 16 (7%) had major handicaps (GOS score of 3 or 4; Table 5 ). GOS scores were not influenced by the stroke subtype diagnoses. Disability, as measured by the BI, was limited; 193 (92%) of responding patients had a score of 19 or 20 ( Table 5 ). The amount of residual disability was not influenced by the initial stroke subtype diagnoses. The sum scores of the MMSE and the NIH stroke scale are in shown in Table 5 ; there were no differences between subgroups categorized by presumed cause of the initial stroke.
Overall, only 133 of the 274 (49%) patients for whom we had complete follow-up information were alive, had not suffered from a recurrent vascular event, had not undergone major vascular surgery, and were not disabled (GOS of 1) at the end of the follow-up. The quality of life was affected more than other functions; approximately 50% of the patients complained about residual problems with their physical or social functioning (Table 6 ). Quality-of-life scores were not significantly different among the different stroke subtypes. Approximately 55% of the patients mentioned that they had had periods of depression after their stroke, and 28% reported to be depressed at the time they completed the questionnaire. However, as many as 46% of responders were classified as depressed based on the results of the SFHQ. The cause of stroke did not influence the frequency of depression. Only 42% of our patients had a job, and in 23% of them adjustments in their occupation were necessary. Of the patients with- •Pneumonia (n=2); AIDS (n=1); and sepsis (n=1). tSystemic lupus erythematosus (n=3); dissection (n=2); moyamoya (n=1); dehydration (n=1); vasculltis (n=3); hypovolemia (n=1); cocaine (n=1); neck cancer (n=1); and trauma (n=1). out a job, 61% were not employed because they were disabled.
Opinions about poststroke rehabilitation and specific rehabilitative interventions were generally very positive. Approximately 40% of the patients had received physical therapy, and 94% of them felt that the intervention was useful. Similar high opinion rates were reported for speech therapy (judged useful by 92%) and occupational therapy (judged useful by 89%). The subtype of stroke did not affect the opinions on rehabilitation.
Discussion
Our experience suggests that ischemic stroke in young adults is not benign; only 49% of our patients had minimal or no disability and were free of recurrent vascular events after a mean follow-up of 6 years. Almost half of the survivors in our series reported important declines in the quality of life. These sequelae, which persisted for years after the initial stroke, involved both physical and emotional problems. One of every 14 of our patients died as a direct result of an ischemic stroke. In subsequent years, the calculated annual incidence of vascular death or recurrent stroke among survivors was 2.6%. In addition, annually, another 3.1% of the patients received medical treatment for management of heart disease or needed a vascular operation. Consequently, on a yearly basis, one of every 17 young adults who survived their initial stroke had another serious vascular event.
For 10 patients, we knew only that they were alive, but we had no information about recurrent events. Fortunately, the baseline data of these patients were similar to those in whom we did obtain complete data. Another factor that may have influenced our results was the selection of patients at baseline. This is a referralbased instead of a population-based study. Thus, a large number of complicated and less straightforward cases may have been enrolled. However, ischemic stroke in a young adult is an unusual event that often results in referral to a specialized center such as ours. Most of our patients are from rural areas or small cities, and thus our experience might differ from practices in large cities. For this reason substance abuse as a cause of stroke definitely is underrepresented in our series. In addition, most of our patients are of European ancestry, and therefore our experience may not be completely applicable to an African-American or Asian-American community. Another limitation of our study was the ascertainment of recurrent stroke only by questionnaire. As a consequence we may have missed some events that occurred during follow-up, and we could not get detailed information about vascular surgery or the subtype of a recurrent stroke. However, our main aim was to study prognosis in terms of quality of life, which means that events that were not mentioned by the patients probably did not cause serious problems.
There are few other reports about the long-term prognosis of young adults with ischemic stroke. Snyder and Ramirez-Lassepas 13 reported relatively low rates of vascular death or recurrent stroke. However, they followed their patients for only 3 years. The long-term outcome was relatively good among persons younger than 30 years in one study. 7 Patients who were younger (25 years or less) also had a better long-term prognosis than the older patients in our series. The reports of Chancellor et al 4 and Federico et al 11 were also generally favorable. Our experience differs. However, we followed our patients for much longer periods and included some assessments up to 16 years after stroke. In this series, almost 75% of survivors had minimal or no disability. This experience is similar to that reported by Chancellor et al. 4 However, many of our patients were unemployed primarily as the result of neurological impairments. This finding concurs with the experience of Federico et al, 11 who reported that 80% of their patients had no or minimal neurological residuals but that only 43% had returned to work. Nearly all of our patients had positive feelings about organized rehabilitation and its components. In addition, the reduction in smoking and use of oral contraceptives may reflect a more positive attitude toward personal care.
Stroke may have severe and long-lasting physical, emotional, and social consequences. 23 Ours is the first large study that performed quality-of-life measurements in young adult survivors of ischemic stroke. Such measurements detected more physical and emotional limitations than could be found by other measures. Social problems and depression were reported by more than half of the respondents. While the quality-of-life measures are comprehensive, they are also very subjective. For example, depression may have substantially influenced the scores of quality of life. Depression is an important long-term adverse effect of stroke in young adults. Depression was widely reported and was commonly detected by the depression screening component of the SFHQ. We recognize that this instrument is not as sensitive or specific as other depression rating scales. However, it does provide clues about the prevalence of this side effect. Depression may be explained by a number of factors. Beside the biological effects of the stroke and concerns about the residual neurological impairments, financial problems, anxiety, and uncertainty about the future may play an important role.
Although quality-of-life measurement in patients with stroke has been considered one of the most important ways to measure outcome after stroke, it has received little attention. 24 -25 Few of these methods have been used or validated. Consequently, selecting qualityof-life instruments always means making concessions. 24 We chose the SFHQ because it combines physical and emotional items, it has good reliability and validity, and it can be completed within 10 minutes. However, to date, it has not been used for patients with stroke, and it was originally developed for older patients.
In conclusion, after 6 years, less than one half of our patients were free of new vascular events and were not disabled. Besides rehabilitation and measures to prevent recurrent vascular events, treatment after shortterm hospitalization should include measures to control risk factors and attempts to increase employment and quality of life.
